AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32916339 — intervention group
Group type: EXPERIMENTAL
Intervention: Respiratory rehabilitation program
Number of subjects: 28
Study 32916339 — intervention group
Group type: COMPARATOR
Intervention: Routine nursing care (Control)
Number of subjects: 28
Study 36481177 — intervention group
Group type: EXPERIMENTAL
Intervention: Reiki
Number of subjects: 93
Study 36481177 — intervention group
Group type: COMPARATOR
Intervention: Sham Reiki
Number of subjects: 93
Study 36481177 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 93
Study 33159496 — intervention group
Group type: EXPERIMENTAL
Intervention: Peginterferon alpha2b
Number of subjects: 114
Study 34016663 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional supplementation with food rations (750 kcal and 23 g proteins/day) and multivitamins for HHC
Number of subjects: 11200
Study 34016663 — intervention group
Group type: COMPARATOR
Intervention: Usual diet for HHC
Number of subjects: 11200
Study 34016663 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional supplementation (monthly food rations supplying 1200 kcal and 52 g proteins/day) and multivitamins along with antitubercular treatment for patients
Number of subjects: 11200
Study 34016663 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional assessment and counselling for both arms
Number of subjects: 11200
Study 34016663 — intervention group
Group type: EXPERIMENTAL
Intervention: Substudies examining micronutrient status and effects on dietary intake, body composition, muscle strength and immune function
Number of subjects: 11200
Study 33487438 — intervention group
Group type: EXPERIMENTAL
Intervention: Food monitoring
Number of subjects: 1010
Study 33487438 — intervention group
Group type: EXPERIMENTAL
Intervention: Permanent monitoring with real-time physician-generated feedback
Number of subjects: 1010
Study 33487438 — intervention group
Group type: COMPARATOR
Intervention: Public-sector data handling
Number of subjects: 1010
Study 35994789 — intervention group
Group type: EXPERIMENTAL
Intervention: Nedaplatin 30 mg/m2
Number of subjects: 160
Study 35994789 — intervention group
Group type: COMPARATOR
Intervention: Cisplatin 40 mg/m2
Number of subjects: 160
Study 32672806 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimedia educational intervention (video and booklet)
Number of subjects: 186
Study 32672806 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 186
Study 33082512 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone (2–2.5 mg/kg)
Number of subjects: 92
Study 33082512 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 92
Study 33271891 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive interventions including nutrition education and physical activity
Number of subjects: 6764
Study 33271891 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 6764
Study 35315706 — intervention group
Group type: EXPERIMENTAL
Intervention: Wii sports-based strategy training
Number of subjects: 192
Study 35315706 — intervention group
Group type: COMPARATOR
Intervention: Traditional balance training (Control)
Number of subjects: 192
Study 32184197 — intervention group
Group type: EXPERIMENTAL
Intervention: Toolkit intervention delivered to primary care practices
Number of subjects: 60
Study 32184197 — intervention group
Group type: COMPARATOR
Intervention: Pre-intervention data (control)
Number of subjects: 60
Study 32171634 — intervention group
Group type: EXPERIMENTAL
Intervention: Boricua Youth Study wave 4 assessment
Number of subjects: 2491
Study 35285811 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted Facebook campaign
Number of subjects: 386
Study 35285811 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 386
Study 35897006 — intervention group
Group type: EXPERIMENTAL
Intervention: rt‐PA + T group (low-dose rt-PA 0.6 mg/kg + tirofiban for 24 hours)
Number of subjects: 60
Study 35897006 — intervention group
Group type: COMPARATOR
Intervention: rt‐PA group (standard dose rt-PA 0.9 mg/kg)
Number of subjects: 60
Study 35897006 — intervention group
Group type: COMPARATOR
Intervention: Comparison of any ICH rates between rt‐PA + T and rt‐PA groups
Number of subjects: 60
Study 35897006 — intervention group
Group type: COMPARATOR
Intervention: Comparison of early neurological deterioration events (END) between rt‐PA + T and rt‐PA groups
Number of subjects: 60
Study 33482030 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultraviolet radiation (UV) treatment
Number of subjects: 0
Study 33482030 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulphuric acid-based fertilizer (SA) treatment
Number of subjects: 0
Study 33482030 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 35366831 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified FOLFOXIRI or modified FOLFOX6 for 6 months
Number of subjects: 0
Study 35366831 — intervention group
Group type: COMPARATOR
Intervention: Observation and scheduled follow-up computed tomography scans
Number of subjects: 0
Study 32959431 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual screen‐based stress management programme (V‐DESSERTS), individual‐based, twice‐daily sessions
Number of subjects: 0
Study 32959431 — intervention group
Group type: COMPARATOR
Intervention: Waitlisted control group (WL)
Number of subjects: 0
Study 32186326 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy low-carbohydrate diet
Number of subjects: 49
Study 32186326 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy low-fat diet
Number of subjects: 49
Study 32186326 — intervention group
Group type: EXPERIMENTAL
Intervention: Both diets
Number of subjects: 49
Study 35312379 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiomics nomogram based on multiparametric MRI (mpMRI)
Number of subjects: 233
Study 35312379 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiomics nomogram
Number of subjects: 233
Study 35312379 — intervention group
Group type: EXPERIMENTAL
Intervention: Calibration curve of the radiomics nomogram
Number of subjects: 233
Study 35312379 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision curve analysis
Number of subjects: 233
Study 33140499 — intervention group
Group type: EXPERIMENTAL
Intervention: Group-based motor and cognitive combined intervention (8-week program, group exercise and cognitive stimulation, twice per week for 45 min)
Number of subjects: 31
Study 33140499 — intervention group
Group type: EXPERIMENTAL
Intervention: Group-based motor and cognitive combined intervention
Number of subjects: 31
Study 33140499 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 31
Study 33561623 — intervention group
Group type: EXPERIMENTAL
Intervention: Capsaicin
Number of subjects: 55
Study 33561623 — intervention group
Group type: EXPERIMENTAL
Intervention: Capsaicin (early administration)
Number of subjects: 55
Study 33561623 — intervention group
Group type: COMPARATOR
Intervention: No Capsaicin
Number of subjects: 55
Study 32185634 — intervention group
Group type: EXPERIMENTAL
Intervention: Kedo‐SG Blue (rotary file system)
Number of subjects: 60
Study 32185634 — intervention group
Group type: EXPERIMENTAL
Intervention: Kedo‐S (paediatric rotary files)
Number of subjects: 60
Study 32185634 — intervention group
Group type: EXPERIMENTAL
Intervention: Kedo‐SH (paediatric hand files)
Number of subjects: 60
Study 32185634 — intervention group
Group type: COMPARATOR
Intervention: Hand K‐files (control group)
Number of subjects: 60
Study 35788774 — intervention group
Group type: EXPERIMENTAL
Intervention: Lymph Node Ratio (LNR) ≤ 0.41
Number of subjects: 141
Study 35788774 — intervention group
Group type: EXPERIMENTAL
Intervention: Lymph Node Ratio (LNR)
Number of subjects: 141
Study 35788774 — intervention group
Group type: COMPARATOR
Intervention: Short interval between radiotherapy and surgery
Number of subjects: 141
Study 35788774 — intervention group
Group type: COMPARATOR
Intervention: Long interval between radiotherapy and surgery
Number of subjects: 141
Study 34528317 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga intervention (individual yoga practices at home, 10 weeks duration)
Number of subjects: 160
Study 34528317 — intervention group
Group type: COMPARATOR
Intervention: Control group (no yoga intervention)
Number of subjects: 160
Study 34881930 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided self-help cognitive-behavioral therapy (3 months)
Number of subjects: 222
Study 34881930 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control condition
Number of subjects: 222
Study 34819115 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily healthy behavior text messaging and weekly self-measured blood pressure monitoring
Number of subjects: 0
Study 32036701 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to a friend's suicide
Number of subjects: 18
Study 32036701 — intervention group
Group type: EXPERIMENTAL
Intervention: Close friends with the person who died
Number of subjects: 18
Study 32036701 — intervention group
Group type: EXPERIMENTAL
Intervention: Peripheral friends
Number of subjects: 18
Study 34856038 — intervention group
Group type: EXPERIMENTAL
Intervention: Guedes‐Pinto paste (GP)
Number of subjects: 61
Study 34856038 — intervention group
Group type: COMPARATOR
Intervention: Calcium Hydroxide and iodoform paste (CaOH/Iodof; Vitapex®)
Number of subjects: 61
Study 32028393 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine (2 × 40 mg daily) + Pelvic Floor Muscle Training (PFMT) for 12 weeks
Number of subjects: 0
Study 32028393 — intervention group
Group type: COMPARATOR
Intervention: Duloxetine (2 × 40 mg daily)
Number of subjects: 0
Study 35836478 — intervention group
Group type: EXPERIMENTAL
Intervention: Koji amazake (118 g/day)
Number of subjects: 60
Study 35836478 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 35836478 — intervention group
Group type: EXPERIMENTAL
Intervention: Koji amazake
Number of subjects: 60
Study 36266133 — intervention group
Group type: EXPERIMENTAL
Intervention: AERO intervention (tailored exercise adherence strategies based on a brief behavioural assessment plus standard physiotherapy)
Number of subjects: 48
Study 36266133 — intervention group
Group type: COMPARATOR
Intervention: Usual care (standard physiotherapy only)
Number of subjects: 48
Study 34611065 — intervention group
Group type: EXPERIMENTAL
Intervention: A‐PRF + hyaluronic acid (HA)
Number of subjects: 0
Study 34611065 — intervention group
Group type: EXPERIMENTAL
Intervention: A‐PRF
Number of subjects: 0
Study 34611065 — intervention group
Group type: COMPARATOR
Intervention: Sodium chloride 0.9% (control)
Number of subjects: 0
Study 32319204 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose milk protein (pasteurized milk and milk protein powder)
Number of subjects: 485
Study 32319204 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose milk protein (condensed milk)
Number of subjects: 485
Study 32319204 — intervention group
Group type: COMPARATOR
Intervention: Negative double-blind placebo-controlled food challenge tests
Number of subjects: 485
Study 32319204 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptoms during introduction
Number of subjects: 485
Study 32319204 — intervention group
Group type: EXPERIMENTAL
Intervention: Pasteurized milk as test material
Number of subjects: 485
Study 35833564 — intervention group
Group type: EXPERIMENTAL
Intervention: CP/BPO 1.2%/3.75% gel
Number of subjects: 495
Study 35833564 — intervention group
Group type: EXPERIMENTAL
Intervention: tretinoin 0.05% lotion
Number of subjects: 495
Study 35833564 — intervention group
Group type: EXPERIMENTAL
Intervention: tazarotene 0.045% lotion
Number of subjects: 495
Study 34865392 — intervention group
Group type: EXPERIMENTAL
Intervention: Support Vector Machine (SVM) model based on 7 optimal features in arterial phase (AP)
Number of subjects: 148
Study 34865392 — intervention group
Group type: EXPERIMENTAL
Intervention: Random Forest model based on 14 optimal features in portal venous phase (PP)
Number of subjects: 148
Study 34865392 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision Tree model based on 7 optimal features in AP
Number of subjects: 148
Study 34865392 — intervention group
Group type: EXPERIMENTAL
Intervention: Extreme Gradient Boosting model based on 7 optimal features in AP
Number of subjects: 148
Study 34865392 — intervention group
Group type: EXPERIMENTAL
Intervention: Generalized Linear Model based on 7 optimal features in AP
Number of subjects: 148
Study 34865392 — intervention group
Group type: EXPERIMENTAL
Intervention: Neural Network model based on 7 optimal features in AP
Number of subjects: 148
Study 34865392 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision Tree model based on 14 optimal features in PP
Number of subjects: 148
Study 34865392 — intervention group
Group type: EXPERIMENTAL
Intervention: Extreme Gradient Boosting model based on 14 optimal features in PP
Number of subjects: 148
Study 34865392 — intervention group
Group type: EXPERIMENTAL
Intervention: Generalized Linear Model based on 14 optimal features in PP
Number of subjects: 148
Study 34865392 — intervention group
Group type: EXPERIMENTAL
Intervention: Neural Network model based on 14 optimal features in PP
Number of subjects: 148
Study 35302197 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium bicarbonated Ringer's solution
Number of subjects: 96
Study 32488427 — intervention group
Group type: EXPERIMENTAL
Intervention: Trazodone ER formulation (300 mg)
Number of subjects: 44
Study 32488427 — intervention group
Group type: COMPARATOR
Intervention: Originator Trittico XR (300 mg)
Number of subjects: 44
Study 33871023 — intervention group
Group type: EXPERIMENTAL
Intervention: Shower group (n=26)
Number of subjects: 51
Study 33871023 — intervention group
Group type: COMPARATOR
Intervention: Non-shower group (n=25)
Number of subjects: 51
Study 35921451 — intervention group
Group type: EXPERIMENTAL
Intervention: Prasinezumab 1500 mg
Number of subjects: 316
Study 35921451 — intervention group
Group type: EXPERIMENTAL
Intervention: Prasinezumab 4500 mg
Number of subjects: 316
Study 35921451 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 316
Study 35921451 — intervention group
Group type: COMPARATOR
Intervention: Dopamine transporter levels (SPECT)
Number of subjects: 316
Study 35921451 — intervention group
Group type: EXPERIMENTAL
Intervention: Serious adverse events
Number of subjects: 316
Study 35921451 — intervention group
Group type: EXPERIMENTAL
Intervention: Infusion reactions
Number of subjects: 316
Study 34654180 — intervention group
Group type: EXPERIMENTAL
Intervention: Static (quenched) disorder in oscillator positions
Number of subjects: 0
Study 34654180 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomly moving oscillators (ballistically or diffusively)
Number of subjects: 0
Study 33122738 — intervention group
Group type: EXPERIMENTAL
Intervention: Proximity extension assay measuring ST2, interleukin‐6, pentraxin‐3, interleukin‐10, renin, and myoglobin
Number of subjects: 131
Study 33122738 — intervention group
Group type: EXPERIMENTAL
Intervention: Proximity extension assay measuring TNF‐related apoptosis‐inducing ligand, TNF‐related activation induced cytokine, interleukin‐16, and cystatin B
Number of subjects: 131
Study 36322332 — intervention group
Group type: COMPARATOR
Intervention: Placebo (ZOE-50)
Number of subjects: 280
Study 36322332 — intervention group
Group type: COMPARATOR
Intervention: Placebo (ZOE-70)
Number of subjects: 280
Study 36322332 — intervention group
Group type: COMPARATOR
Intervention: Placebo (ZOE-HSCT)
Number of subjects: 280
Study 32794259 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3 mg aldafermin
Number of subjects: 176
Study 32794259 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg aldafermin
Number of subjects: 176
Study 32794259 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 mg aldafermin
Number of subjects: 176
Study 32794259 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 mg aldafermin
Number of subjects: 176
Study 32794259 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 176
Study 32891140 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Insomnia (CBT-I)
Number of subjects: 28
Study 32891140 — intervention group
Group type: COMPARATOR
Intervention: Health Education (HE)
Number of subjects: 28
Study 34521108 — intervention group
Group type: EXPERIMENTAL
Intervention: Id-KLH vaccine
Number of subjects: 36
Study 34521108 — intervention group
Group type: COMPARATOR
Intervention: KLH only
Number of subjects: 36
Study 32026838 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal manipulation and myofascial release (SMMRG)
Number of subjects: 72
Study 32026838 — intervention group
Group type: COMPARATOR
Intervention: Spinal manipulation alone (SMG)
Number of subjects: 72
Study 35701639 — intervention group
Group type: EXPERIMENTAL
Intervention: CTG + FBS
Number of subjects: 1013
Study 35701639 — intervention group
Group type: COMPARATOR
Intervention: CTG + STAN
Number of subjects: 1013
Study 33518380 — intervention group
Group type: EXPERIMENTAL
Intervention: E-learning narrative intervention group
Number of subjects: 39
Study 33518380 — intervention group
Group type: COMPARATOR
Intervention: Active control condition
Number of subjects: 39
Study 32399632 — intervention group
Group type: COMPARATOR
Intervention: Placebo arm of a smoking cessation study
Number of subjects: 130
Study 35177153 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile-based brief intervention (BI)
Number of subjects: 74
Study 35177153 — intervention group
Group type: EXPERIMENTAL
Intervention: Face-to-face brief intervention (BI)
Number of subjects: 74
Study 35177153 — intervention group
Group type: COMPARATOR
Intervention: Active control (information leaflet)
Number of subjects: 74
Study 34548085 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency augmented feedback (AF) group
Number of subjects: 30
Study 34548085 — intervention group
Group type: EXPERIMENTAL
Intervention: Faded augmented feedback (AF) group
Number of subjects: 30
Study 34548085 — intervention group
Group type: COMPARATOR
Intervention: Control group (no AF)
Number of subjects: 30
Study 32948200 — intervention group
Group type: COMPARATOR
Intervention: Platelet Rich Plasma (PRGF®)
Number of subjects: 60
Study 32948200 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 × 106 cultured autologous bone marrow mesenchymal stromal cells (BM‐MSCs) plus PRGF®
Number of subjects: 60
Study 32993385 — intervention group
Group type: EXPERIMENTAL
Intervention: Speech disfluencies per 100 words and 100 syllables in children aged 6-9 years
Number of subjects: 54
Study 32993385 — intervention group
Group type: EXPERIMENTAL
Intervention: Criterion <3 stuttering-like disfluencies (SLD) per 100 syllables
Number of subjects: 54
Study 32993385 — intervention group
Group type: EXPERIMENTAL
Intervention: Criterion <3 SLD per 100 words
Number of subjects: 54
Study 32404646 — intervention group
Group type: EXPERIMENTAL
Intervention: Lu-177 tin colloid
Number of subjects: 57
Study 32404646 — intervention group
Group type: COMPARATOR
Intervention: Re-188 tin colloid
Number of subjects: 57
Study 37843475 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided erector spinae plane block (ESPB)
Number of subjects: 46
Study 37843475 — intervention group
Group type: COMPARATOR
Intervention: Sham procedure
Number of subjects: 46
Study 33247306 — intervention group
Group type: EXPERIMENTAL
Intervention: HP-TDR (high-protein total diet replacement)
Number of subjects: 43
Study 33247306 — intervention group
Group type: COMPARATOR
Intervention: CON (control diet)
Number of subjects: 43
Study 35314471 — intervention group
Group type: EXPERIMENTAL
Intervention: iCT-PTSD-YP
Number of subjects: 34
Study 35314471 — intervention group
Group type: COMPARATOR
Intervention: Waiting List (WL)
Number of subjects: 34
Study 33825070 — intervention group
Group type: EXPERIMENTAL
Intervention: PA + Charity (N=26; Fitbit, step goal, electronic weekly newsletter + charity donation if step goal achieved)
Number of subjects: 51
Study 33825070 — intervention group
Group type: COMPARATOR
Intervention: PA (N=25; Fitbit, step goal, electronic weekly newsletter)
Number of subjects: 51
Study 33825070 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 51
Study 33825070 — intervention group
Group type: EXPERIMENTAL
Intervention: PA + Charity
Number of subjects: 51
Study 35946244 — intervention group
Group type: EXPERIMENTAL
Intervention: MTA (Mineral Trioxide Aggregate; Proroot Dentsply/Tulsa) with smear layer
Number of subjects: 60
Study 35946244 — intervention group
Group type: EXPERIMENTAL
Intervention: CEM (Calcium‐Enriched Mixture; Bionique Dent, Tehran) with smear layer
Number of subjects: 60
Study 35946244 — intervention group
Group type: EXPERIMENTAL
Intervention: ERRM (EndoSequence® Root Repair Material; Brasseler USA, Savannah, GA) with smear layer
Number of subjects: 60
Study 35946244 — intervention group
Group type: EXPERIMENTAL
Intervention: ERRM without smear layer
Number of subjects: 60
Study 35946244 — intervention group
Group type: EXPERIMENTAL
Intervention: CEM without smear layer
Number of subjects: 60
Study 35946244 — intervention group
Group type: EXPERIMENTAL
Intervention: MTA without smear layer
Number of subjects: 60
Study 33595936 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryotherapy
Number of subjects: 0
Study 33595936 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous Electrical Nerve Stimulation (TENS)
Number of subjects: 0
Study 33595936 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryotherapy combined with TENS
Number of subjects: 0
Study 33595936 — intervention group
Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 0
Study 35205004 — intervention group
Group type: EXPERIMENTAL
Intervention: Family Nurture Intervention (FNI)
Number of subjects: 72
Study 35205004 — intervention group
Group type: COMPARATOR
Intervention: Standard Care (SC)
Number of subjects: 72
Study 32291620 — intervention group
Group type: EXPERIMENTAL
Intervention: Furosemide/albumin
Number of subjects: 49
Study 32291620 — intervention group
Group type: COMPARATOR
Intervention: Furosemide
Number of subjects: 49
Study 34562750 — intervention group
Group type: EXPERIMENTAL
Intervention: Lenvatinib 14 mg/m2
Number of subjects: 31
Study 32545062 — intervention group
Group type: EXPERIMENTAL
Intervention: Moringa oleifera (MO) leaf extract
Number of subjects: 0
Study 32545062 — intervention group
Group type: COMPARATOR
Intervention: Iron tablets
Number of subjects: 0
Study 34762764 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention (1-hour discussion among staff using audit and feedback data)
Number of subjects: 4935
Study 34762764 — intervention group
Group type: COMPARATOR
Intervention: Control (standard practice without the educational intervention)
Number of subjects: 4935
Study 32194164 — intervention group
Group type: EXPERIMENTAL
Intervention: Wavelet phase coherence analysis of cerebral oxyhemoglobin (HbO2) in frequency interval III (0.05–0.15 Hz)
Number of subjects: 83